Apellis Pharmaceuticals, Inc.
Overview
Apellis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of treatments targeting the complement system to address a wide range of diseases, including rare and debilitating conditions. The company aims to leverage its deep understanding of the complement cascade in developing innovative therapies.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Apellis Pharmaceuticals, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.